Thus, these findings indicate that: i) AAT is readily secreted from injured tubules (consistent with the immunohistochemistry results); and ii) urinary AAT levels might have early AKI biomarker utility (seemingly comparable in that regard to NGAL). This evidence concerns the gene SERPINA1 and acute kidney injury.